We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

96 hedge funds and large institutions have $12.4M invested in Zomedica Corp. in 2024 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 13

0% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 16

0% less capital invested

Capital invested by funds: $12.4M → $12.4M (-$21.3K)

3% less funds holding

Funds holding: 99 → 96 (-3)

Holders
96
Holders Change
-3
Holders Change %
-3.03%
% of All Funds
1.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
16
Reduced
16
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
+$412K
2
State Street
State Street
Massachusetts
+$59.8K
3
SWM
Spire Wealth Management
Virginia
+$32.9K
4
TSS
Two Sigma Securities
New York
+$32.2K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$27.8K

Top Sellers

Rank Fund Capital Flow
1
AI
Atom Investors
Texas
-$175K
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$139K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$76.8K
4
Citadel Advisors
Citadel Advisors
Florida
-$44.9K
5
XT
XTX Topco
Cayman Islands
-$35.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
GF
26
Gabelli Funds
New York
$14.6K – – –
Bank of New York Mellon
27
Bank of New York Mellon
New York
$14.6K – – –
UBS Group
28
UBS Group
Switzerland
$10.6K -$22.2K -148,455 -67%
HighTower Advisors
29
HighTower Advisors
Illinois
$10K – – –
I
30
INVST
Indiana
$9.96K -$26 -175 -0.3%
TRCT
31
Tower Research Capital (TRC)
New York
$9.95K +$9.69K +64,686 +1,868%
NA
32
NewEdge Advisors
Louisiana
$8.92K +$5.24K +35,000 +135%
VFG
33
Victory Financial Group
Texas
$8.77K – – –
SOS
34
Silver Oak Securities
Tennessee
$8.59K – – –
CJ
35
Caitlin John
Michigan
$8.55K -$300 -2,000 -3%
Cambridge Investment Research Advisors
36
Cambridge Investment Research Advisors
Iowa
$7K +$150 +1,000 +2%
GJIA
37
Glass Jacobson Investment Advisors
Maryland
$6.99K +$749 +5,000 +12%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$6.64K -$3.65K -24,395 -35%
GSC
39
Ground Swell Capital
South Carolina
$6.21K -$34.6K -230,650 -84%
WEG
40
World Equity Group
Illinois
$5.85K – – –
TSWM
41
Tyler-Stone Wealth Management
Ohio
$5.84K – – –
PCIA
42
Prime Capital Investment Advisors
Kansas
$5.71K – – –
AWM
43
AE Wealth Management
Kansas
$4.43K +$4.54K +30,312 New
BW
44
Bison Wealth
Georgia
$4.03K – – –
Wells Fargo
45
Wells Fargo
California
$4.02K -$1.41K -9,427 -26%
SAW
46
Signal Advisors Wealth
Michigan
$3.65K +$1.48K +9,900 +66%
MWM
47
Maripau Wealth Management
Indiana
$3.65K +$1.5K +10,000 +67%
JCM
48
Jacobi Capital Management
Pennsylvania
$3.34K – – –
Cerity Partners
49
Cerity Partners
New York
$3.26K – – –
TWM
50
Tradition Wealth Management
Minnesota
$3.23K – – –
1
2
3 4 5

ZOM Hedge Fund Activity: Q2 2024 in Review

96 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2024, worth a combined $12.4M — down 0.17% from $12.4M a quarter earlier.

Fund positioning in ZOM was balanced in Q2 2024: 13 funds opened new positions, 13 closed out, 16 added to existing stakes and 16 trimmed.

The largest buyer was GSA Capital Partners, adding an estimated $412K. The largest seller was Atom Investors, exiting entirely with an estimated $175K sold.

  • 96 institutional investors held Zomedica Corp. (ZOM) as of Q2 2024, down from 99 in Q1 2024.
  • Funds reported $12.4M of Zomedica Corp. stock for Q2 2024, down 0.17% quarter-over-quarter.
  • 13 funds opened new Zomedica Corp. positions in Q2 2024 and 13 closed out, a net change of 0 holders.
  • The largest Zomedica Corp. buyer in Q2 2024 was GSA Capital Partners, an estimated $412K added.
  • The largest Zomedica Corp. seller in Q2 2024 was Atom Investors, an estimated $175K sold.

Based on aggregated 13F filings for Q2 2024.